Civic Intelligence

Carson Sarcoma Foundation

990EZ • Fiscal year 2017 • EIN 46-4728821

Jan 01, 2017 to Dec 31, 2017 • Filed on Nov 15, 2018

PO Box 2212Asheville, NC 28802

(412) 996-6643

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

Score unavailable

No value available

Liabilities-to-assets requires both liabilities and assets on this filing.

Source year 2017

Liabilities / Revenue

Score unavailable

No value available

Liabilities-to-revenue requires both liabilities and revenue on this filing.

Source year 2017

Net Margin

4th percentile

-133%

Higher net margin than 4% of similar nonprofits.

2017 filings • 501(c)3 • <$500k nonprofits • Source year 2017

Top Officer Pay

76th percentile

$0

Higher top officer pay than 76% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2017 filings • 501(c)3 • <$500k nonprofits • Source year 2017

Asset Growth

8th percentile

-52%

Faster asset growth than 8% of similar nonprofits.

2017 filings • 501(c)3 • <$500k nonprofits • Annualized from 2016 to 2017

Revenue Growth

3rd percentile

-89%

Faster revenue growth than 3% of similar nonprofits.

2017 filings • 501(c)3 • <$500k nonprofits • Annualized from 2016 to 2017

Assets

Down

$47,822

Down $52,729 (-52%) from 2016

Net Assets

Down

$47,822

Down $52,729 (-52%) from 2016

Liabilities

-

No earlier filing loaded for comparison.

Revenue

Down

$39,743

Down $324,102 (-89%) from 2016

Expenses

Down

$92,472

Down $259,611 (-74%) from 2016

Net Income

Down

-$52,729

Down $64,491 (-548%) from 2016

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$300K$200K$100K$0Assets 2015: $88,789Net Assets 2015: $88,7892015Assets 2016: $100,551Liabilities 2016: $0Net Assets 2016: $100,5512016Assets 2017: $47,822Net Assets 2017: $47,8222017Assets 2018: $131,812Net Assets 2018: $131,8122018Assets 2019: $101,011Net Assets 2019: $101,0112019Assets 2020: $164,990Net Assets 2020: $164,9902020Assets 2021: $256,564Liabilities 2021: $0Net Assets 2021: $256,5642021Assets 2022: $225,871Net Assets 2022: $225,8712022Assets 2023: $0Net Assets 2023: $02023

Highlighted filing

2017

Assets$47,822
Liabilities-
Net Assets$47,822

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$400K$200K$0-$200K-$400KRevenue 2015: $129,461Expenses 2015: $40,672Net Income 2015: $88,7892015Revenue 2016: $363,845Expenses 2016: $352,083Net Income 2016: $11,7622016Revenue 2017: $39,743Expenses 2017: $92,472Net Income 2017: -$52,7292017Revenue 2018: $127,558Expenses 2018: $43,568Net Income 2018: $83,9902018Revenue 2019: $41,508Expenses 2019: $72,309Net Income 2019: -$30,8012019Revenue 2020: $127,068Expenses 2020: $101,304Net Income 2020: $25,7642020Revenue 2021: $283,758Expenses 2021: $192,184Net Income 2021: $91,5742021Revenue 2022: $21,150Expenses 2022: $51,843Net Income 2022: -$30,6932022Revenue 2023: $23,581Expenses 2023: $249,452Net Income 2023: -$225,8712023

Highlighted filing

2017

Revenue$39,743
Expenses$92,472
Net Income-$52,729
Jump To
Filing Snapshot
Filing Period
Jan 1, 2017 to Dec 31, 2017
Signed
Nov 15, 2018
Return Version
2017v2.3
Gross Receipts
$39,743
Mission and Program Overview

Mission

Csf raises funds through families/friends touched by ewing's sarcoma. Efforts will expand to include raising funds from private individuals, corporations, and online activities. Csf partners with a wide array of individuals & institutions to complete csf's mission. These could include, but are not limited to, cancer hospitals, cancer research institutions, other cancer foundations, scientists, biologists, oncologists and pathologists. Csf focuses on targeted cancer research. Targeted cancer research seeks to attack cancer cells while leaving normal cells unharmed. Examples of targeted cancer research include immunotherapy & molecular therapy. Csf seeks out promising therapies that can be utilized by patients within 12-24 months. Csf seeks out projects whose goal is to move their research to stage 1 clinical trials within 24 months.

Program Services

DescriptionGrantsExpenses
THE MISSION OF THE CARSON SARCOMA FOUNDATION IS TO FUND TARGETED CANCER RESEARCH FOCUSED ON INCREASING SURVIVAL FOR THOSE STRICKEN WITH ORPHAN SARCOMA CANCERS ULTIMATELY LEADING TO A CURE. THE INITIAL FOCUS IS ON EWING'S SARCOMA CANCER.$90,000$90,000
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
CHRISTOPHER C CARSONCo-Director-$0--
RANDY W CARSONCo-Director-$0--
DR G THOMAS BUDDBoard Member-$0--
ROBERT NOYES-SMITHBoard Member-$0--
Filing and Contact Details

Filer

Filer Name
Carson Sarcoma Foundation
EIN
46-4728821
Phone
4129966643
Address
PO BOX 2212, ASHEVILLE, NC 28802

Signing Officer

Name
Randy W Carson
Title
Co-director
Phone
4129966643
Signed
2018-11-15
Discuss with paid preparer
Yes

Preparer

Firm
Austin CPA Pc
Address
301 W HAYWOOD ST, ASHEVILLE, NC 28801-3104
Preparer
Joel Chambers
Phone
8287851556
Supplemental Narrative

Additional Explanations

Form 990-ez, Part I, Line 10

Name: md anderson cancer center address: 1515 holcombe blvd houston, tx 77030 cash contribution: 65,000 name: cleveland clinic cancer research address: 9500 euclid ave cleveland, oh 44195 cash contribution: 25,000

Form 990-ez, Part I, Line 16

Expenses paypal fees 435 google 1,150 bank fees 37 total 1,622

Form 990-ez, Part III

Csf raises funds through families/friends touched by ewing's sarcoma. Efforts will expand to include raising funds from private individuals, corporations, and online activities. Csf partners with a wide array of individuals & institutions to complete csf's mission. These could include, but are not limited to, cancer hospitals, cancer research institutions, other cancer foundations, scientists, biologists, oncologists and pathologists. Csf focuses on targeted cancer research. Targeted cancer research seeks to attack cancer cells while leaving normal cells unharmed. Examples of targeted cancer research include immunotherapy & molecular therapy. Csf seeks out promising therapies that can be utilized by patients within 12-24 months. Csf seeks out projects whose goal is to move their research to stage 1 clinical trials within 24 months.

Form 990-ez, Part III, Line 28

The mission of the carson sarcoma foundation is to fund targeted cancer research focused on increasing survival for those stricken with orphan sarcoma cancers ultimately leading to a cure. The initial focus is on ewing's sarcoma cancer.

Raw XML Appendix138 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd0false
IRS990EZ/BooksInCareOfDetail/PersonNm0RANDY W CARSON
IRS990EZ/BooksInCareOfDetail/PhoneNum08283333448
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt092 MIDDLEMONT AVE
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0ASHEVILLE
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0NC
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd028801
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt0100551
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt047822
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd0false
IRS990EZ/ContributionsGiftsGrantsEtcAmt039743
IRS990EZ/DonorAdvisedFndsInd0false
IRS990EZ/EngagedInExcessBenefitTransInd0false
IRS990EZ/ExcessOrDeficitForYearAmt0-52729
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt0850
IRS990EZ/FiledScheduleAInd0true
IRS990EZ/ForeignFinancialAccountInd0false
IRS990EZ/ForeignOfficeInd0false
IRS990EZ/Form1120PolFiledInd0false
IRS990EZ/Form990TotalAssetsGrp/BOYAmt0100551
IRS990EZ/Form990TotalAssetsGrp/EOYAmt047822
IRS990EZ/GrantsAndSimilarAmountsPaidAmt090000
IRS990EZ/GrossReceiptsAmt039743
IRS990EZ/InfoInScheduleOPartIIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/LobbyingActivitiesInd0false
IRS990EZ/MadeLoansToFromOfficersInd0false
IRS990EZ/MethodOfAccountingCashInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt0100551
IRS990EZ/NetAssetsOrFundBalancesEOYAmt047822
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt0100551
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt047822
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt0000.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt1000.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt2000.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt3000.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0CHRISTOPHER C CARSON
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1RANDY W CARSON
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2DR G THOMAS BUDD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3ROBERT NOYES-SMITH
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0CO-DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1CO-DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2BOARD MEMBER
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3BOARD MEMBER
IRS990EZ/OperateHospitalInd0false
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd0false
IRS990EZ/OrganizationHadUBIInd0false
IRS990EZ/OtherExpensesTotalAmt01622
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd0false
IRS990EZ/PrimaryExemptPurposeTxt0CSF RAISES FUNDS THROUGH FAMILIES/FRIENDS TOUCHED BY EWING'S SARCOMA. EFFORTS WILL EXPAND TO INCLUDE RAISING FUNDS FROM PRIVATE INDIVIDUALS, CORPORATIONS, AND ONLINE ACTIVITIES. CSF PARTNERS WITH A WIDE ARRAY OF INDIVIDUALS & INSTITUTIONS TO COMPLETE CSF'S MISSION. THESE COULD INCLUDE, BUT ARE NOT LIMITED TO, CANCER HOSPITALS, CANCER RESEARCH INSTITUTIONS, OTHER CANCER FOUNDATIONS, SCIENTISTS, BIOLOGISTS, ONCOLOGISTS AND PATHOLOGISTS. CSF FOCUSES ON TARGETED CANCER RESEARCH. TARGETED CANCER RESEARCH SEEKS TO ATTACK CANCER CELLS WHILE LEAVING NORMAL CELLS UNHARMED. EXAMPLES OF TARGETED CANCER RESEARCH INCLUDE IMMUNOTHERAPY & MOLECULAR THERAPY. CSF SEEKS OUT PROMISING THERAPIES THAT CAN BE UTILIZED BY PATIENTS WITHIN 12-24 MONTHS. CSF SEEKS OUT PROJECTS WHOSE GOAL IS TO MOVE THEIR RESEARCH TO STAGE 1 CLINICAL TRIALS WITHIN 24 MONTHS.
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0THE MISSION OF THE CARSON SARCOMA FOUNDATION IS TO FUND TARGETED CANCER RESEARCH FOCUSED ON INCREASING SURVIVAL FOR THOSE STRICKEN WITH ORPHAN SARCOMA CANCERS ULTIMATELY LEADING TO A CURE. THE INITIAL FOCUS IS ON EWING'S SARCOMA CANCER.
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt090000
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt090000
IRS990EZ/ProhibitedTaxShelterTransInd0false
IRS990EZ/RelatedOrganizationCtrlEntInd0false
IRS990EZ/ScheduleBNotRequiredInd0X
IRS990EZ/SchoolOperatingInd0false
IRS990EZ/SubjectToProxyTaxInd0false
IRS990EZ/TanningServicesProvidedInd0false
IRS990EZ/TotalExpensesAmt092472
IRS990EZ/TotalProgramServiceExpensesAmt090000
IRS990EZ/TotalRevenueAmt039743
IRS990EZ/TransactionWithControlEntInd0false
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0HTTP://WWW.CARSONSARCOMAFOUNDATION.ORG
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt039743
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt0363845
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt0129461
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus3YearsAmt0363845
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt0896894
IRS990ScheduleA/InvestmentIncomeCYPct00.00000
IRS990ScheduleA/InvestmentIncomePYPct00.00000
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportCY509Pct01.00000
IRS990ScheduleA/PublicSupportPY509Pct01.00000
IRS990ScheduleA/PublicSupportTotal509Amt0896894
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind0X
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt039743
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt0363845
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt0129461
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt0363845
IRS990ScheduleA/Total509Grp/TotalAmt0896894
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt039743
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt0363845
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt0129461
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt0363845
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt0896894
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0NAME: MD ANDERSON CANCER CENTER ADDRESS: 1515 HOLCOMBE BLVD HOUSTON, TX 77030 CASH CONTRIBUTION: 65,000 NAME: CLEVELAND CLINIC CANCER RESEARCH ADDRESS: 9500 EUCLID AVE CLEVELAND, OH 44195 CASH CONTRIBUTION: 25,000
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1EXPENSES PAYPAL FEES 435 GOOGLE 1,150 BANK FEES 37 TOTAL 1,622
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2CSF RAISES FUNDS THROUGH FAMILIES/FRIENDS TOUCHED BY EWING'S SARCOMA. EFFORTS WILL EXPAND TO INCLUDE RAISING FUNDS FROM PRIVATE INDIVIDUALS, CORPORATIONS, AND ONLINE ACTIVITIES. CSF PARTNERS WITH A WIDE ARRAY OF INDIVIDUALS & INSTITUTIONS TO COMPLETE CSF'S MISSION. THESE COULD INCLUDE, BUT ARE NOT LIMITED TO, CANCER HOSPITALS, CANCER RESEARCH INSTITUTIONS, OTHER CANCER FOUNDATIONS, SCIENTISTS, BIOLOGISTS, ONCOLOGISTS AND PATHOLOGISTS. CSF FOCUSES ON TARGETED CANCER RESEARCH. TARGETED CANCER RESEARCH SEEKS TO ATTACK CANCER CELLS WHILE LEAVING NORMAL CELLS UNHARMED. EXAMPLES OF TARGETED CANCER RESEARCH INCLUDE IMMUNOTHERAPY & MOLECULAR THERAPY. CSF SEEKS OUT PROMISING THERAPIES THAT CAN BE UTILIZED BY PATIENTS WITHIN 12-24 MONTHS. CSF SEEKS OUT PROJECTS WHOSE GOAL IS TO MOVE THEIR RESEARCH TO STAGE 1 CLINICAL TRIALS WITHIN 24 MONTHS.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3THE MISSION OF THE CARSON SARCOMA FOUNDATION IS TO FUND TARGETED CANCER RESEARCH FOCUSED ON INCREASING SURVIVAL FOR THOSE STRICKEN WITH ORPHAN SARCOMA CANCERS ULTIMATELY LEADING TO A CURE. THE INITIAL FOCUS IS ON EWING'S SARCOMA CANCER.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990-EZ, PART I, LINE 10
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990-EZ, PART I, LINE 16
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990-EZ, PART III
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990-EZ, PART III, LINE 28
ReturnHeader/BuildTS02019-02-21 02:37:17Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0RANDY W CARSON
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0CO-DIRECTOR
ReturnHeader/BusinessOfficerGrp/PhoneNum04129966643
ReturnHeader/BusinessOfficerGrp/SignatureDt02018-11-15
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0CARSON SARCOMA FOUNDATION
ReturnHeader/Filer/BusinessNameControlTxt0CARS
ReturnHeader/Filer/EIN0464728821
ReturnHeader/Filer/PhoneNum04129966643
ReturnHeader/Filer/USAddress/AddressLine1Txt0PO BOX 2212
ReturnHeader/Filer/USAddress/CityNm0ASHEVILLE
ReturnHeader/Filer/USAddress/StateAbbreviationCd0NC
ReturnHeader/Filer/USAddress/ZIPCd028802
ReturnHeader/FilingSecurityInformation/AtSubmissionCreationDeviceId0315617DD8AEAA661E87AB88E0DB6B0CBD2670E6F
ReturnHeader/FilingSecurityInformation/AtSubmissionFilingDeviceId031B790AA375F2D2E18DF29AB54BFF46998C28841
ReturnHeader/FilingSecurityInformation/FilingLicenseTypeCd0P
ReturnHeader/FilingSecurityInformation/IPAddress/IPv4AddressTxt0167.68.16.49
ReturnHeader/FilingSecurityInformation/IPDt02018-11-07
ReturnHeader/FilingSecurityInformation/IPTimezoneCd0CS
ReturnHeader/FilingSecurityInformation/IPTm021:57:29
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0463060158
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0AUSTIN CPA PC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt0301 W HAYWOOD ST
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0ASHEVILLE
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0NC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd0288013104
ReturnHeader/PreparerPersonGrp/PhoneNum08287851556
ReturnHeader/PreparerPersonGrp/PreparationDt02018-11-07
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0JOEL CHAMBERS
ReturnHeader/ReturnTs02018-11-07T22:57:29-05:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02017-01-01
ReturnHeader/TaxPeriodEndDt02017-12-31
ReturnHeader/TaxYr02017

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Peer Organizations

Similar nonprofits based on the same Siviq industry and scale cohort. 2017 filings • 501(c)3 • <$500k nonprofits